Patents by Inventor Tarik Soliman

Tarik Soliman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vitamin D-ghrelin conjugates
    Patent number: 9173950
    Abstract: The invention provides carriers that enhance the absorption, half-life or bioavailability of Ghrelin peptides. The carriers comprise targeting groups that bind the Vitamin D Binding protein (DBP), conjugation groups for coupling the targeting groups to the therapeutic compounds, and optionally scaffolding moieties.
    Type: Grant
    Filed: November 15, 2014
    Date of Patent: November 3, 2015
    Assignee: Extend Biosciences, Inc.
    Inventors: Tarik Soliman, Laura M. Hales, Howard P. Sard, Mukkanti Amere
  • CARRIERS FOR IMPROVED DRUG DELIVERY
    Publication number: 20150104469
    Abstract: The invention provides carriers that enhance the absorption, half-life or bioavailability of therapeutic compounds. The carriers comprise targeting groups that bind the Vitamin D Binding protein (DBP), conjugation groups for coupling the targeting groups to the therapeutic compounds, and optionally scaffolding moieties.
    Type: Application
    Filed: March 14, 2013
    Publication date: April 16, 2015
    Applicant: Extend Biosciences, Inc.
    Inventors: Tarik Soliman, Laura M. Hales, Howard P. Sard, Mukkanti Amere
  • VITAMIN D-GHRELIN CONJUGATES
    Publication number: 20150065420
    Abstract: The invention provides carriers that enhance the absorption, half-life or bioavailability of Ghrelin peptides. The carriers comprise targeting groups that bind the Vitamin D Binding protein (DBP), conjugation groups for coupling the targeting groups to the therapeutic compounds, and optionally scaffolding moieties.
    Type: Application
    Filed: November 15, 2014
    Publication date: March 5, 2015
    Applicant: EXTEND BIOSCIENCES, INC.
    Inventors: Tarik Soliman, Laura M. Hales, Howard P. Sard, Mukkanti Amere
  • Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms
    Patent number: 8137928
    Abstract: The present invention provides enhanced methods of producing soluble, active eukaryotic glycosyltransferases in prokaryotic microorganisms that have an oxidizing environment.
    Type: Grant
    Filed: March 24, 2006
    Date of Patent: March 20, 2012
    Assignee: BioGeneriX
    Inventors: Marc F. Schwartz, Tarik Soliman
  • Expression of soluble therapeutic proteins
    Patent number: 8043833
    Abstract: The present invention provides enhanced methods of producing soluble, active fibroblast growth factor-20 (FGF-20), FGF-21, neurotrophin-3 (NT-3), growth hormone (GH), granulocyte colony stimulating factor (G-CSF), or glucocerebrosidase proteins in microorganisms that have an oxidizing environment.
    Type: Grant
    Filed: September 6, 2006
    Date of Patent: October 25, 2011
    Assignee: Novo Nordisk A/S
    Inventors: Marc F. Schwartz, Bingyuan Wu, Aliakbar Mobasseri, Shawn A. DeFrees, Tarik Soliman, Karl F. Johnson
  • EXPRESSION OF SOLUBLE, ACTIVE EUKARYOTIC GLYCOSYLTRANSFERASES IN PROKARYOTIC ORGANISMS
    Publication number: 20110223646
    Abstract: The present invention provides enhanced methods of producing soluble, active eukaryotic glycosyltransferases in prokaryotic microorganisms that have an oxidizing environment.
    Type: Application
    Filed: March 28, 2011
    Publication date: September 15, 2011
    Applicant: BIOGENERIX AG
    Inventors: Marc F. Schwartz, Tarik Soliman
  • EXPRESSION OF SOLUBLE, ACTIVE EUKARYOTIC GLYCOSYLTRANSFERASES IN PROKARYOTIC ORGANISMS
    Publication number: 20100143969
    Abstract: The present invention provides enhanced methods of producing soluble, active eukaryotic glycosyltransferases in prokaryotic microorganisms that have an oxidizing environment.
    Type: Application
    Filed: March 24, 2006
    Publication date: June 10, 2010
    Applicant: Neose Technologies, Inc.
    Inventors: Marc F. Schwartz, Tarik Soliman
  • EXPRESSION OF SOLUBLE THERAPEUTIC PROTEINS
    Publication number: 20090298121
    Abstract: The present invention provides enhanced methods of producing soluble, active fibroblast growth factor-20 (FGF-20), FGF-21, neurotrophin-3 (NT-3), growth hormone (GH), granulocyte colony stimulating factor (G-CSF), or glucocerebrosidase proteins in microorganisms that have an oxidizing environment.
    Type: Application
    Filed: September 6, 2006
    Publication date: December 3, 2009
    Inventors: Marc F. Schwartz, Bingyuan Wu, Aliakbar Mobasseri, Shawn A. DeFrees, Tarik Soliman, Karl F. Johnson
  • Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms
    Publication number: 20060234345
    Abstract: The present invention provides enhanced methods of producing soluble, active eukaryotic glycosyltransferases in prokaryotic microorganisms that have an oxidizing environment.
    Type: Application
    Filed: March 24, 2006
    Publication date: October 19, 2006
    Applicant: Neose Technologies, Inc.
    Inventors: Marc Schwartz, Tarik Soliman